GYNECOLOGY

9: The prevalence of chlamydia in adolescents at presentation to colposcopy: do new cervical cancer screening guidelines eliminate an STI screening opportunity?

May 5, 2017 by in GYNECOLOGY Comments Off on 9: The prevalence of chlamydia in adolescents at presentation to colposcopy: do new cervical cancer screening guidelines eliminate an STI screening opportunity?

Objectives Sexually transmitted infections (STIs) lead to female reproductive morbidity, are frequently asymptomatic, and rates continue to rise. Adolescents are known to be at high risk for STIs and have…

read more

7: Is more always better? comparing nucleic acid amplification testing to traditional methods in diagnosis of vaginal infections in gynecology and vulvovaginal referral offices

May 5, 2017 by in GYNECOLOGY Comments Off on 7: Is more always better? comparing nucleic acid amplification testing to traditional methods in diagnosis of vaginal infections in gynecology and vulvovaginal referral offices

Objectives Nucleic acid amplification testing (NAAT) is commercially available for the diagnosis of vaginitis, but only validated in the setting of a STD clinic. The aim of this study was…

read more

6: A phase 2 randomized, double-blind, placebo-controlled study to evaluate the effectiveness and safety of single, oral doses of SYM-1219, a granule formulation containing 1 and 2 gram doses of secnidazole, for the treatment of women with bacterial vaginosis

May 5, 2017 by in GYNECOLOGY Comments Off on 6: A phase 2 randomized, double-blind, placebo-controlled study to evaluate the effectiveness and safety of single, oral doses of SYM-1219, a granule formulation containing 1 and 2 gram doses of secnidazole, for the treatment of women with bacterial vaginosis

Objectives SYM-1219, a granule formulation of secnidazole, a 5-nitroimidazole with a longer half-life (∼17 hr) than metronidazole (∼8 hr), is being developed to treat bacterial vaginosis (BV). Secnidazole has been…

read more

5: Injectable progestin contraception and vaginal infection among south african women participating in the VOICE trial

May 5, 2017 by in GYNECOLOGY Comments Off on 5: Injectable progestin contraception and vaginal infection among south african women participating in the VOICE trial

Objectives Data are limited on the potential impact of the injectable progestin contraceptives (IPC) norethisterone enanthate on risk of vaginal infections. We assessed whether users of two common IPC (depot…

read more

4: Delayed clearance of chlamydia trachomatis infection in the presence of an levonorgestrel intrauterine device in a non-human primate model

May 5, 2017 by in GYNECOLOGY Comments Off on 4: Delayed clearance of chlamydia trachomatis infection in the presence of an levonorgestrel intrauterine device in a non-human primate model

Objectives Chlamydia trachomatis (Ct)-associated pelvic inflammatory disease (PID) is a major source of morbidity and infertility. The influence of intrauterine devices (IUD) on the pathogenesis of PID is unknown. The…

read more
Get Clinical Tree app for offline access